Cesar Fisac

Summary

Affiliation: Hospital Universitari de Bellvitge
Country: Spain

Publications

  1. ncbi request reprint A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled study
    Cesar Fisac
    Endocrinology Services, Hospital Universitario de Bellvitge, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    J Clin Endocrinol Metab 88:5186-92. 2003
  2. ncbi request reprint Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine
    Cesar Fisac
    Nutrition Section, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
    AIDS 19:917-25. 2005
  3. ncbi request reprint Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study
    Daniel Podzamczer
    Infectious Disease Service, Hospital Universitari de Bellvitge, Barcelona, Spain
    J Acquir Immune Defic Syndr 44:139-47. 2007
  4. ncbi request reprint Switching strategies to improve lipid profile and morphologic changes
    Patricia Barragan
    Infectious Disease Service, Hospital Universitari de Bellvitge, L Hospitalet, Barcelona, Spain
    AIDS Rev 8:191-203. 2006

Detail Information

Publications4

  1. ncbi request reprint A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled study
    Cesar Fisac
    Endocrinology Services, Hospital Universitario de Bellvitge, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    J Clin Endocrinol Metab 88:5186-92. 2003
    ..Inclusion of NVP should be considered when deciding upon antiretroviral regimens for patients at high coronary risk...
  2. ncbi request reprint Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine
    Cesar Fisac
    Nutrition Section, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
    AIDS 19:917-25. 2005
    ..To evaluate the 24-month metabolic and morphological benefits obtained from replacing the protease inhibitor (PI) in a regimen with nevirapine, efavirenz or abacavir...
  3. ncbi request reprint Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study
    Daniel Podzamczer
    Infectious Disease Service, Hospital Universitari de Bellvitge, Barcelona, Spain
    J Acquir Immune Defic Syndr 44:139-47. 2007
    ..To assess lipoatrophy, other toxicities, and efficacy associated with abacavir as compared with stavudine in HIV-infected antiretroviral-naive patients...
  4. ncbi request reprint Switching strategies to improve lipid profile and morphologic changes
    Patricia Barragan
    Infectious Disease Service, Hospital Universitari de Bellvitge, L Hospitalet, Barcelona, Spain
    AIDS Rev 8:191-203. 2006
    ..In this setting, switching strategies may be useful to minimize clinical and psychological consequences, improving the quality of life of HIV-infected patients treated with HAART...